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Summary 
Unresponsiveness to self is maintained through two mechanisms of immune regulation: thy- 
talc-negative selection and peripheral tolerance. Although thymic-negative selection is a major 
mechanism to eliminate sell-reactive T  ceils, normal mice have readily detectable populations 
ofT cells reactive to sell-proteins but do not exhibit autoimmune responses. It has been postu- 
lated  that  autoimmune  disease  results  from breakdown  or loss  of peripheral  tolerance.  We 
present data that demonstrate that peripheral tolerance or unresponsiveness to self can be bro- 
ken in nonobese diabetic (NOD) mice. Immunization of NOD mice (but not of conventional 
mice) with sell-peptides caused an immune response to the sell-peptide with resultant autopro- 
liferation of  peripheral lymphocytes. Autoproliferation of  self-reactive T cells in NOD mice re- 
sulted from the recognition and proliferation of  the activated T cells to endogenously processed 
and presented sell-antigens. This loss of self-tolerance demonstrated in vitro may well be the 
basis of NOD autoimmune disease in vivo. 
Puzzle in understanding sell-tolerance has been the dis- 
covery of  populations oft  cells reactive to sell-peptides 
in normal mice, as well as the presence of functional sell- 
peptide MHC complexes, in the absence of discernible au- 
toimmune responses. Lorenz and Allen (1, 2) demonstrated 
functional self-hemoglobin/class II complexes in CBA/J mice. 
Agrawal et al. (3) subsequently found T  cells spontaneously 
reactive to self-MHC peptides in BALB/c mice, presum- 
ably due to endogenous priming by functional MHC/MHC 
peptide complexes, but these cells produced no detectable 
autoreactivity. In a double transgenic model, Ohashi  et al. 
(4) constructed mice with pancreatic ~-cell expression of a 
lymphocytic choriomeningitis virus (LCMV) 1 glycoprotein, 
as well as CD8 + transgenic T  ceils reactive with the glyco- 
protein. Despite the demonstration that the LCMV glyco- 
protein was expressed with the appropriate MHC class I as- 
sociation in  the  pancreas  and  the  demonstration  that  the 
cytotoxic lymphocytes bearing the  transgeneic  TCIK  were 
neither deleted nor anergized, the mice showed no signs of 
autoreactivity to the endogenous antigen. The coexistence 
of autoreactive T  cells  and  functional self-peptide MHC 
complexes in the periphery, in the absence of autoreactiv- 
ity,  has  been  explained as peripheral  unresponsiveness  or 
tolerance. Here we present studies on breaking peripheral 
tolerance in nonobese diabetic (NOD) mice. 
The NOD mouse is a model ofautoimmune diabetes with 
tAbbreviations used in this paper: LCMV, lymphocytic  choriomeningitis  vi- 
res; MM, mouse myoglobin; NOD, nonobese diabetic; PPD, purified 
protein derivative;  SWM, sperm whale myoglobin. 
T  cell-mediated pancreatic islet inflammation (insulitis) and 
resultant f~-cell destruction. NOD mice, however, suffer an 
array of  coexisting spontaneous autoimmune phenomena with 
lymphocytic infiltration into many organs, including salivary 
and lacrimal  glands,  thyroid, parathyroid,  adrenal  cortex, 
bowel,  and testes  (5-7).  Multiple  autoantigens have been 
defined in NOD  mice, e.g.,  glutamic acid decarboxylase, 
peripherin, carboxypeptidase H, insulin,  and heat-shock pro- 
teins have been demonstrated as targets of spontaneous au- 
toimmunity (8, 9). These data suggest that a global immune 
regulatory defect, rather than  recognition of a  single  au- 
toantigen, may be responsible for NOD autoimmune phe- 
nomenon. Here we describe a novel model ofdisregulation 
of sell-reactivity in NOD mice in which immunization of 
NOD mice but not normal DBA/2 mice, with sell-peptides 
produced a breakdown of tolerance and an autoproliferative 
response in "peripheral lymphocytes". We show that this au- 
toproliferation is specific for self-peptides,  that it does not oc- 
cur in response to foreign peptides, and that it utilizes CD4 +, 
MHC class II-restricted T cells. Once activated,  these T cells, 
unlike T cells in normal DBA/2 mice, recognize and prolif- 
erate in response to endogenously processed and presented 
self-antigens.  This model of  loss of  self-tolerance in vitro may 
prove useful for exploring the immune regulatory defect that 
underlies the diffuse autoreactivity of NOD mice in vivo. 
Materials and Methods 
Mice.  NOD  mice were bred  and  housed  in  the  Stanford 
Medical Center Department of Laboratory and Animal Medicine 
(DLAM). Mice were used between the ages of  8 and 12 wk (10re- 
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tory (Bar Harbor, ME) and maintained in DLAM. 
Peptides.  TCR.  peptide V1~8.2 38--60  (DTGHGLRLIHYS- 
YGAGSTEKGDI) and sperm whale myoglobin (SWM) 110-121 
(AIIHVLHSR_HPG)  were  prepared and  HPLC  purified at  the 
Protein and Nucleic Acid Facility, Beckman Center, at Stanford 
University (Stanford, CA). TCt~ peptide VI36 38-60 (DSGKGL- 
RLIYYSITENDLQKGDL),  mouse myoglobin (MM)  110-121 
(IIIEVLKKRHSG), MM 69-78 (LTALGTILKK), and ribosomal 
$30 peptide 75-96 (KVHGSLARAGKVR.GQTPKVAKQ) were 
synthesized and purified at Immulogic Pharmaceutical Corp. (Palo 
Alto, CA). 
Antigen Proliferation Assays.  Mice were immunized at the base 
of the tail with either CFA plus 10 mg/ml heat-killed Mycobacte- 
rium tuberculosis, H37RA  (Difco Laboratories Inc., Detroit, MI) 
alone, or 100  I~g of peptide suspended in Dulbecco's-PBS and 
emulsified with an equal volume of CFA plus 10 mg/ml H37RA 
(Difco). 6-14  d  after immunization, draining inguinal LN  cells 
were removed and single-cell  suspensions were prepared. 5 ￿  105 
cells were incubated in 96-well flat-bottom plates in either T  cell 
media alone or with titrated doses of antigen or purified-protein 
derivative (PPD). T  cell media consisted of RPMI  1640  supple- 
mented with 2 mM r-glutamine, penicillin/streptomycin, nones- 
sential amino acids, sodium pyruvate, and 10 mM Hepes buffer 
(Gibco Laboratories, Grand Island, NY),  50 mM 2-ME  (Sigma 
Chemical Co.,  St.  Louis MO),  and 0.5% normal mouse serum. 
After 72 h  at 37~  6%  CO2,  cells were pulsed with  1 IxCi of 
[3H]thymidine and harvested 18 h later. 
Naive NOD peripheral lymphocytes were obtained from the 
LN of naive mice, made into single-cell suspensions, and irradi- 
ated with 3,300 rads. 
Anti-CD4 mAb was obtained and purified from the B cell hy- 
bridoma GK 1.5.  Anti-MHC class II antibody 10.3.6  was pur- 
chased from Pharmingen (La Jolla, CA). 
Minimacs Purification of CD4 Cells.  Single-cell suspensions  of 
freshly isolated LN cells were counted and incubated with anti- 
CD4 magnetic microbeads (Miltenyi Biotec, Auburn, CA) for 15 
min at 4~  washed, and then purified by passing through mag- 
netic flow columns. The CD4-depleted fraction was subsequently 
used for reconstitution experiments (see below). 
Results 
DBA/2  and NOD  Responses to Foreign and Self-Myoglobin 
Peptides.  Our lab has characterized the mouse T  cell im- 
mune response to the SWM peptide amino acids 110-121 
in several mouse strains (10,  11). SWM  110-121  differs by 
five amino acids from the corresponding MM  110-121  self- 
peptide. After immunization,  DBA/2  mice  demonstrate a 
normal, immunogenic response to the foreign peptide SWM 
110-121  (as previously reported [10,  11]). After immuniza- 
tion with the self-peptide MM  110-121,  they showed no 
reactivity at tested dose levels (Fig. 1 A). NOD  mice, when 
immunized with the foreign peptide SWM 110-121, showed 
a similar T  cell proliferative response that was characteristic 
of a normal immune response with titratable dose-response 
kinetics (Fig. 1 B). However, NOD  mice responded to im- 
munization with the self-myoglobin peptide MM  110-121 
with  an  unusual  autoproliferation of draining LN  cells in 
media alone, which was unaffected by the addition of the 
exogenous immunizing antigen at the tested doses (Fig. 1 B). 
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Figure 1.  DBA/2 and NOD responses to foreign and self-myoglobin 
peptides. Groups of  three 8-12-wk-old female DBA/2 (A) or male or fe- 
male NOD (B) mice were immunized in the base of the tail with 5 ￿ 
CFA and 100 I~g of either SWM 110-121 or MM 110-121. Draining LN 
cells were harvested after 6-14 d and cultured in tissue culture media plus 
antigen in triplicate wells  for 3 d before pulsing with tritiated thymidine. 
PPD  responses were  as  follows: SWM-immunized  NOD,  103,708; 
SWM-immunized DBA/2,  146,454; MM-immunized  NOD,  151,534; 
MM-immunized DBA/2, 175,842. Each experiment was repeated three 
or more times. SEMs were <10% in all experiments. (Open squares) re- 
sponse of SWM-immunized  animals to  SWM  peptide;  (diamonds) re- 
sponse of MM-immunized animals to MM peptide. 
Autoproliferative  Response  of NOD  to  Other  Self-Peptides. 
We next asked whether this autoproliferative phenomenon 
was restricted to recognition of MM  t10-121  or reflected a 
wider disregulation of self-reactivity in NOD  mice. A  sec- 
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(V[~6 and V[~8 amino acids 38-60), and a peptide from the 
widespread cellular ribosomal protein $30 all induced auto- 
proliferation in NOD  mice but not in DBA/2  mice  after 
immunization. The presence  of self-peptide in the immu- 
nizing emulsion was  essential, as age-matched NOD  mice 
immunized with  CFA  alone showed  no  autoproliferative 
response. Thus autoproliferation is antigen driven (Fig. 2). 
MHC  Class  II-restricted  CD4 + Cells  Mediate Autoprolifer- 
ation.  Addition  of anti-CD4  antibody,  but  not  isotype- 
matched  control antibodies, blocked  the  autoproliferation 
in a  dose-dependent fashion (Fig. 3 A), demonstrating that 
the  autoproliferation  was  due  to  the  response  of CD4 + 
cells. We  demonstrated that self-antigen was presented on 
APC in association with NOD  MHC  class II by the addi- 
tion of anti-class II antibody to  titrated numbers of whole 
LN cells taken from self-peptide immunized mice (as anti- 
gen-reactive  T  cells)  plus  irradiated  naive  LN  cells  (as 
APCs).  The  anti-class II antibodies blocked autoprolifera- 
tion  with  efficacy  similar  to  that  of anti-CD4  antibodies 
(Fig. 3  B). 
Fractionation and Mixing Studies Show That Autoproliferating 
Cells Recognize Endogenous Antigen.  Single minimacs puri- 
fication of CD4 +  cells from  autoproliferating whole  LN- 
cell preparations  from  NOD  mice  immunized with  MM 
110-121  (which in our hands produced cells that were 95% 
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Figure  2.  Autoproliferative response of NOD  to  other  self-peptides. 
Groups of three 8-12-wk-old NOD mice (five different experiments are 
shown) were immunized  with either 100 p,g peptide in 5 ￿  CFA, or 5 ￿ 
CFA alone, in the base of the tail. PPD responses were as follows: V~8.2 
38-60, 286,228  (open triangles); V[$6 38-60,  163,940 (open circles); MM 
69-78, 224,261 (open squares); ribosomal $30 75-96,  186,173 (open dia- 
monds); CFA alone,  246,162  (crossed squares)￿9 Each  experiment  was re- 
peated three or more times. The CFA and MM 69-79 experiments used 
male or female mice; the $30 and TCR peptide experiments used female 
NOD mice. 
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Figure 3.  Effect  of anti-CD4 or anti-MHC class II antibodies on the 
autoproliferative response.  (A) Effect of anti-CD4 on autoproliferating 
cells. Coarse stippling shows the $30 response, fine stippling, TCRP V[38.2 
38--60 response. The proliferation in media alone was 240,537 cpm in the 
$30 experiment;  476,836 cpm in the TCRP VI38.2 38-60 experiment. 
(/3) Effect of anti-MHC class II antibody on the autoproliferative  re- 
sponse. 5.0 ￿  l0  s MM 110-121-immunized LN cells were cultured with 
5.0 ￿  10  s irradiated naive NOD LN cells in media alone or media plus 10 
~g/ml of antibody  10.3.6 (cross-reactive with I-Ag~). Each experiment 
was repeated three or more times. 
1659  Pddgway et al. CD4 positive  by FACS  |  analysis)  showed that  the  CD4- 
enriched autoproliferating T  cells had a markedly decreased 
proliferation when compared with unfractionated LN cells, 
consistent with the removal of the APC fraction from these 
CD4-enriched cells (Fig. 4 A). ILeconstitution of the CD4- 
enriched cells with the  CD4 depleted portion,  which car- 
ries the majority of the APC fraction, restored autoprolifer- 
ation (Fig. 4 A). 
The  demonstration  that  CD4  cells  from  immunized 
NOD  mice  recognized  endogenously processed  and  pre- 
sented self-antigen was achieved by the addition  of CD4 + 
minimacs-enriched cells (from animals immunized with self- 
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Figure  4.  Fractionation and mixing studies of autoproliferating cells: 
recognition of endogenous self-antigen. (+t) LN cells from NOD mice 
immunized with self-peptides were incubated with anti-CD4 magnetic 
microbeads for 15 rmn at 4~  washed, and enriched by passing through 
magnetic flow columns. The CD4(-) fraction was used for reconstitu- 
tion. (First bar) MM 110-121-immunized unfractionated LN cells; (middle 
bar) MM 1100121-immunized CD4 + cells alone; (third bar) MM 110--121 
CD4 + cells reconstituted with CD4-cells. (B) In a separate experiment, 
self-peptide (/VIM 110o121) immunized, minimacs enriched CD4 + cells 
were mixed with irradiated naive NOD LN cells as APCs. (First bar) Irra- 
diated naive NOD LN cells alone; (second  bar)  CD4 + MM  110-121- 
immunized cells alone; (third  bar) mixing of naive irradiated cells with 
MM 110-121-immunized CD4 + cells. Each experiment was repeated at 
least three times. 
peptide)  to single-cell suspensions of naive irradiated NOD 
LN cells as APCs (Fig. 4 B). Vigorous autoproliferation re- 
sulted from the addition of the self-peptide-primed  CD4 + 
T  cells  to unprimed APCs.  Priming the  NOD  mice with 
self-peptide  was  essential,  as  addition  of CD4 +  cells  from 
control NOD mice to irradiated naive LN cells did not pro- 
duce autoproliferation. 
These data strongly support our hypothesis that autopro- 
liferation  is  mediated  by  antigen-specific  CD4 +  cells  re- 
sponding  to  endogenously  processed  self-peptides  pre- 
sented by MHC  class II on APCs. 
Discussion 
We have developed a novel model to study the loss of  self- 
tolerance in NOD  mice in vitro, which may reflect critical 
mechanisms underlying NOD  autoimmunity in vivo. Data 
presented  above demonstrate  that NOD  mice immunized 
with self-peptides show an autoproliferative response to en- 
dogenously processed  and presented  self-antigens  in  vitro 
after immunization with self-peptides,  which has not been 
demonstrated in any other mouse strain. NOD  autoreactive 
T  cells  persist and expand in the periphery in an exagger- 
ated and poorly regulated fashion as the result of a critical 
immune regulatory defect. An animal model that resembles 
the NOD  global defect in self-reactivity is one developed 
by Sakaguchi  and  Sakaguchi  (12)  in  which  neonatal  cy- 
closporin  A  treatment  and/or  thymectomy  of otherwise 
normal mice allowed expression of multiorgan autoimmu- 
nity,  presumably as  a  result of loss of immune  regulation. 
The  cyclosporin A  model  may have  direct  relevance  for 
understanding  NOD  autoimmunity,  since  it  has  been  re- 
ported  that  cyclosporin A  treatment  can  worsen  autoim- 
munity in NOD  mice (13). The idea ofa pathophysiologi- 
cally important immune regulatory defect in NOD  mice is 
further  supported  by  the  studies  of Dardenne  et  al.  (14), 
which  showed that  early thymectomy increased  the  inci- 
dence  of diabetes  in  NOD  female  mice,  whereas  later  thy- 
mectomy had no effect on disease  incidence.  This finding 
was explained by the  postulated loss of regulatory T  cells. 
Our lab,  as well  as Boitard  et al.  (15,  16),  has shown that 
transfer  of CD4-enriched  prediabetic  spleen  cells  can  sig- 
nificantly delay the  onset of diabetes  induced by adoptive 
transfer  of diabetic  spleen  cells,  which  supports  the  exist- 
ence of a regulatory T  cell subset. 
We have shown that  NOD  mice retain  the  capacity to 
respond normally to foreign peptides while demonstrating an 
abnormal response to self-peptides both in vitro and in vivo. 
Presumably the response to the foreign peptide is regulated 
over time by the disappearance of  the foreign antigen, whereas 
after priming with  exogenously supplied  self-peptide  anti- 
gen, the autoprohferating self-reactive T  cells  are driven by 
the  continuous  presence  of endogenously  processed  and 
presented self-peptides.  The presentation of functional self- 
peptide/MHC  II complexes in vivo has been clearly dem- 
onstrated by Lorenz and Allen (1), who showed that hemo- 
globin-specific T  cell hybridomas from CE/J mice recognize 
hemoglobin peptide on naive hemoglobin allotype--dissim- 
1660  Breaking Self-tolerance in Nonobese Diabetic Mice ilar  CBA/J  APCs.  Their  studies  demonstrated  that  self- 
hemoglobin  peptide  was  present  and  functional  on  APCs 
with  a  wide  tissue  distribution.  CBA/J  mice,  however, 
lacked a  proliferative response  to self-hemoglobin,  despite 
the demonstration  of abundant and functional expression of 
processed  hemoglobin  antigen  appropriately  presented  by 
APC (1, 2). T  cells that recognize self-peptides are demon- 
strably present in other normal mouse strains (e.g., response 
of DBA/2  and [PLJ/SJL]F1  mice to self-TCR peptides), as 
shown in our lab (17); thus, not all autoreactive T  cells are 
clonally deleted.  T  cells from naive BALB/c  mice sponta- 
neously  recognize  self-MHC  II peptides,  presumably  due 
to endogenous priming by functional MHC/MHC  peptide 
complexes,  yet  these  mice  demonstrate  neither  autoim- 
mune sequelae nor autoproliferation in vitro after immuni- 
zation  with  self-peptide  (3).  Double-transgene  models 
demonstrate  that self-reactive T  cells can persist in the pe- 
riphery (at supraphysiologic levels), in the presence of their 
target  self-antigen,  without  discernible  autoreactivity  (4). 
Thus, the limited or regulated recognition of self in normal 
CBA/J, BALB/c, and (PLJ/SJL)F1 mice, or in double trans- 
genic mice, is in marked contrast to our findings of an ex- 
aggerated response to immunization  with self-peptide seen 
in  NOD  mice.  We  postulate  that immunization  of NOD 
mice  with  self-peptides  in  CFA  may mimic  a  pathogenic 
event in  vivo  (e.g.,  an  immune  response  to  an  infectious 
process), which allows cell destruction,  determinant spread- 
ing, and the unveiling of cryptic self-epitopes (18) with re- 
sultant activation ofT cells that recognize and proliferate in 
response  to endogenously  processed self-antigen.  An anal- 
ogy may be drawn  to the  Ohashi  (4)  model,  in which  in- 
fection with live LCMV resulted in the irreversible break- 
down  of self-tolerance  to  the  viral glycoprotein  expressed 
as  self in  the  pancreatic  islets.  This  process  is manifest in 
NOD  mice as autoproliferative  cells in  vitro  and  as  tissue- 
infiltrating  self-reactive  lymphocytes  in  vivo.  The  initial 
event, whether induced by CFA plus peptide or as the im- 
mune response to injury, may break self-tolerance in an ir- 
reversible fashion in NOD  mice. Why NOD  mice possess 
such an apparently large and diverse population  of autore- 
active cells is a matter of conjecture.  One interesting possi- 
bility is that the processes of thymic negative selection  are 
impaired  due  to  the  recently  demonstrated  poor  peptide 
binding characterisitics of the NOD  MHC  class II Iag  7 mol- 
ecules  (19),  which  might  allow  the  escape  of high  affanity 
self-reactive T  cells in NOD  mice compared with conven- 
tional  mice.  Future  studies  on  autoproliferation  in  NOD 
mice may demonstrate that this phenomenon reflects a ma- 
jor defect in the regulation  of peripheral self-tolerance, in- 
complete  thymic  negative  selection,  or  a  combination  of 
both defects, and may further illustrate how autoreactive T 
cells,  in the  setting of defective immune  regulation,  could 
initiate and perpetuate autoimmune disease. 
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